|1.||Tang, Jiping: 15 articles (06/2015 - 10/2004)|
|2.||Zhang, John H: 14 articles (06/2015 - 10/2004)|
|3.||Colbourne, Frederick: 13 articles (03/2015 - 04/2003)|
|4.||Sorsa, Timo: 10 articles (01/2016 - 12/2003)|
|5.||Lekic, Tim: 10 articles (06/2015 - 03/2009)|
|6.||Sorsa, T: 10 articles (06/2006 - 06/2000)|
|7.||Manaenko, Anatol: 9 articles (06/2015 - 03/2009)|
|8.||Hentz, Vincent R: 8 articles (06/2014 - 09/2002)|
|9.||Li, Yi: 7 articles (01/2016 - 09/2004)|
|10.||Lo, Eng H: 7 articles (04/2015 - 05/2009)|
03/01/2006 - "Matrix modification with bacterial collagenase coinjection results in a significant improvement in the initial range of viral distribution within the tumor. "
06/01/1991 - "General proteolytic activity was significantly greater in tumor tissue at all spheroid sizes while only the implantation of 750 microns spheroids resulted in significantly increased collagenase type IV activity. "
02/01/2003 - "Excluding non-smokers improved the specificity of collagenase activity in differentiating cancer and non-malignant disease from 62.5% to 80.0%. "
04/01/1998 - "Tissue harvested from an in vivo R3327H tumor was dissociated with collagenase and placed into Richter's improved media (with supplements). "
03/21/2013 - "In this study, utilizing mice deficient in CTSK, we demonstrate the critical involvement of this potent collagenase in tumor progression in bone. "
|2.||Wounds and Injuries (Trauma)
12/01/2015 - "In particular the patterns of the collagenases MMP-1 and MMP-8 in healing wounds were distinct, with MMP-8 appearing in significantly greater amounts especially in the non-healing group. "
02/01/1999 - "The patterns of the collagenases MMP-1 and MMP-8 in healing wounds were distinct, with MMP-8 appearing in significantly greater amounts than MMP-1. "
05/01/2015 - "Test products, GV/MB antibacterial foam dressing, collagenase ointment, collagenase ointment plus GV/MB antibacterial foam dressing, medical-grade honey, and moist gauze dressing (control), were applied to porcine wounds using a split-back study design. "
11/01/2014 - "Aloe vera: an in vitro study of effects on corneal wound closure and collagenase activity."
09/01/2011 - "Using artificial wound eschar, the optimal pH range for C collagenase was determined to be more than a pH of 6. The total initial microbial load (day 0) was higher than levels at any other time during the study. "
|3.||Dupuytren Contracture (Dupuytrens Contracture)
09/01/2013 - "The use of collagenase injection in the treatment of palmar form of Dupuytren's disease gives good results in the short and medium terms. "
12/01/2014 - "The use of collagenase appears to be an effective and safe method for the treatment of Dupuytren's contracture. "
05/01/1996 - "These results indicate that collagenase may be effective in enzymatic fasciotomy of residual-stage Dupuytren's disease."
09/01/2002 - "The results of these studies indicate that nonoperative collagenase injection therapy for Dupuytren's disease is both a safe and effective method of treating this disorder in the majority of patients as an alternative to surgical fasciectomy. "
06/01/2015 - "Collagenase is a safe and effective outpatient-based treatment for Dupuytren's contracture, which may be useful in controlling surgical waiting lists. "
12/01/2000 - "This led to induction of collagenase expression and reversal of fibrosis with concomitant hepatocyte and improved liver function. "
08/01/2005 - "In conclusion, this study provides 'proof of principle' that collagenase portal administration can retard cirrhosis development and speed regression of established cirrhosis in the rabbit CCl(4) model. "
03/01/1986 - "Clinicopathological study on submucosal injection of collagenase in the treatment of submucous fibrosis in the oral cavity."
11/01/2012 - "We identified the three following TAA phenotypes: phenotype I (cystic medial degeneration balanced by a substitutive fibrosis, in absence of medial apoptosis and with a faint collagenase concentration), phenotype II (cystic medial degeneration of higher grade, respectively, than substitutive fibrosis, with focal medial apoptosis and moderate collagenase concentration), and phenotype III (elevated cystic medial degeneration without substitutive fibrosis, with plurifocal medial apoptosis and severe collagenase concentration). "
02/01/2008 - "Delivery of interstitial collagenases, such as matrix metalloproteinase (MMP)-1, in the liver could be an attractive strategy to treat advanced hepatic fibrosis from the view point that the imbalance between too few interstitial collagenases and too many of their inhibitors is the main obstacle to the resolution from fibrosis. "
08/01/2011 - "In the current study, we propose that autologous tenocytes therapy (ATT) is effective in treating tendon degeneration in a collagenase-induced rabbit Achilles tendinopathy model. "
01/01/2008 - "The data in this study show the efficacy of cBMSC and BMMNC in regenerating tendon tissue after collagenase-induced tendinitis."
01/01/2014 - "The aim of this study was to evaluate tendon derived stem cells (TDSCs) and platelet rich plasma (PRP) in the treatment of collagenase induced Achilles tendinopathy in rat. "
06/01/2013 - "Both original animal and human controlled studies, covering any cell type for the treatment of naturally occurring, overuse or collagenase-induced tendinopathy, and with full text available, were included. "
01/01/2013 - "The aim of this study was to explore whether intratendinous collagenase injection combined with treadmill running created a pathology in the rat Achilles tendon consistent with human Achilles tendinosis. "
|2.||Hyaluronic Acid (Hyaluronan)
|4.||Conditioned Culture Media
|6.||Carbon Tetrachloride (Tetrachloromethane)
|9.||Tissue Inhibitor of Metalloproteinase-1
|4.||Intervertebral Disk Chemolysis (Discolysis)